Long-term follow-up of patients with acute myeloid leukemia surviving and free of disease recurrence for at least 2 years after autologous stem cell transplantation: A report from the Acute Leukemia Working Party of the European Society for Blood an
about
A Two-Phase Expansion Protocol Combining Interleukin (IL)-15 and IL-21 Improves Natural Killer Cell Proliferation and Cytotoxicity against RhabdomyosarcomaMatched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the ALWP of the EBMTLong-Term Outcome of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Acute Myeloid Leukemia (AML)- Single Center Retrospective Analysis.Pitfalls in the molecular follow up of mutant acute myeloid leukemia
P2860
Long-term follow-up of patients with acute myeloid leukemia surviving and free of disease recurrence for at least 2 years after autologous stem cell transplantation: A report from the Acute Leukemia Working Party of the European Society for Blood an
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Long-term follow-up of patient ...... European Society for Blood an
@en
type
label
Long-term follow-up of patient ...... European Society for Blood an
@en
prefLabel
Long-term follow-up of patient ...... European Society for Blood an
@en
P2093
P2860
P356
P1433
P1476
Long-term follow-up of patient ...... European Society for Blood an
@en
P2093
Arnaud Pigneux
Arnon Nagler
Didier Blaise
Eric Beohou
Felicetto Ferrara
Giovanna Meloni
Jan J Cornelissen
Joan Veelken
Mohamad Mohty
Myriam Labopin
P2860
P304
P356
10.1002/CNCR.29990
P407
P577
2016-03-28T00:00:00Z